SE411754B - Forfarande for framstellning av terapeutiskt aktiva nya derivat av n-(2-pyrrolidinylalkyl)-bensamid - Google Patents

Forfarande for framstellning av terapeutiskt aktiva nya derivat av n-(2-pyrrolidinylalkyl)-bensamid

Info

Publication number
SE411754B
SE411754B SE7502342A SE7502342A SE411754B SE 411754 B SE411754 B SE 411754B SE 7502342 A SE7502342 A SE 7502342A SE 7502342 A SE7502342 A SE 7502342A SE 411754 B SE411754 B SE 411754B
Authority
SE
Sweden
Prior art keywords
pyrrolidinylalkyl
benzamide
procedure
preparation
therapeutically active
Prior art date
Application number
SE7502342A
Other languages
English (en)
Other versions
SE7502342L (sv
Inventor
G Bulteau
J Acher
J-C Monier
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7407535A external-priority patent/FR2262966A1/fr
Priority claimed from FR7503800A external-priority patent/FR2299863B1/fr
Application filed by Ile De France filed Critical Ile De France
Publication of SE7502342L publication Critical patent/SE7502342L/xx
Publication of SE411754B publication Critical patent/SE411754B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE7502342A 1974-03-05 1975-03-03 Forfarande for framstellning av terapeutiskt aktiva nya derivat av n-(2-pyrrolidinylalkyl)-bensamid SE411754B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7407535A FR2262966A1 (en) 1974-03-05 1974-03-05 N-(2-azacycloalkyl-alkyl)-benzamide derivs. - with antiemetic, antiulcer and CNS activity
FR7503800A FR2299863B1 (fr) 1975-02-07 1975-02-07 Nouveaux N-(Z-pyrrolidiny alkyl) benzamides substitués, leurs dérivés et leur procédé de préparation

Publications (2)

Publication Number Publication Date
SE7502342L SE7502342L (sv) 1975-09-08
SE411754B true SE411754B (sv) 1980-02-04

Family

ID=26218210

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7502342A SE411754B (sv) 1974-03-05 1975-03-03 Forfarande for framstellning av terapeutiskt aktiva nya derivat av n-(2-pyrrolidinylalkyl)-bensamid

Country Status (27)

Country Link
JP (1) JPS6015616B2 (sv)
AR (1) AR206621A1 (sv)
AT (1) AT358570B (sv)
BG (1) BG24666A3 (sv)
CA (1) CA1047504A (sv)
CH (1) CH605794A5 (sv)
CS (1) CS189692B2 (sv)
DD (1) DD119420A5 (sv)
DE (1) DE2507989A1 (sv)
DK (1) DK145377C (sv)
EG (1) EG12577A (sv)
ES (1) ES435274A1 (sv)
FI (1) FI750620A (sv)
GB (1) GB1466822A (sv)
HK (1) HK14078A (sv)
HU (1) HU170637B (sv)
IE (1) IE40818B1 (sv)
IL (1) IL46696A (sv)
LU (1) LU71949A1 (sv)
NL (1) NL7502608A (sv)
NO (1) NO750713L (sv)
OA (1) OA04966A (sv)
PH (1) PH14197A (sv)
PL (1) PL97091B1 (sv)
RO (2) RO70647A (sv)
SE (1) SE411754B (sv)
SU (1) SU609464A3 (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ186175A (en) * 1977-01-27 1980-03-05 Shionogi & Co Meta-sulphonamidobenzamide derivatives
SE8503054D0 (sv) * 1985-06-19 1985-06-19 Astra Laekemedel Ab Catecholcarboxamides
US4772459A (en) * 1986-09-09 1988-09-20 Erbamont, Inc. Method for controlling emesis caused by chemotherapeutic agents and antiemetic agents useful therein
EP0314483A1 (en) * 1987-10-29 1989-05-03 Erbamont, Inc. Preparation of benzamides
FR2699533A1 (fr) * 1992-12-21 1994-06-24 Mouhtaram Mohamed Dérivés de N-((1,4-dialkyl-6-arylpipérazine-2-yl)méthyl)benzamides. (Isomères cis et trans) Propriétés pharmacologiques et applications.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3078497A (en) * 1960-12-29 1963-02-26 Leeds And Mieallef Dispensing containers

Also Published As

Publication number Publication date
DK145377C (da) 1983-04-11
SU609464A1 (sv) 1978-05-30
JPS50123668A (sv) 1975-09-29
BG24666A3 (en) 1978-04-12
ES435274A1 (es) 1976-12-16
LU71949A1 (sv) 1976-02-04
DE2507989A1 (de) 1975-09-11
CH605794A5 (sv) 1978-10-13
IL46696A (en) 1978-07-31
CS189692B2 (en) 1979-04-30
IE40818B1 (en) 1979-08-29
HU170637B (sv) 1977-07-28
RO70647A (ro) 1980-04-15
PL97091B1 (pl) 1978-02-28
OA04966A (fr) 1980-10-31
JPS6015616B2 (ja) 1985-04-20
AT358570B (de) 1980-09-25
IE40818L (en) 1975-09-05
ATA160775A (de) 1980-02-15
HK14078A (en) 1978-03-23
DD119420A5 (sv) 1976-04-20
NL7502608A (nl) 1975-09-09
CA1047504A (en) 1979-01-30
FI750620A (sv) 1975-09-06
IL46696A0 (en) 1975-04-25
GB1466822A (en) 1977-03-09
DK145377B (da) 1982-11-08
EG12577A (en) 1979-09-30
RO72844A (ro) 1981-09-24
SE7502342L (sv) 1975-09-08
AU7874075A (en) 1976-09-09
SU609464A3 (ru) 1978-05-30
DK86975A (sv) 1975-11-03
NO750713L (sv) 1975-09-08
AR206621A1 (es) 1976-08-06
PH14197A (en) 1981-03-26

Similar Documents

Publication Publication Date Title
SE430329B (sv) Forfarande for framstellning av nya terapeutiskt verksamma foreningar
SE411753B (sv) Forfarande for framstellning av terapeutiskt aktiva nya derivat av n-(1-bensylpyrrolidinyl-2-alkyl)-bensamid
NO149106C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzcykloamider
NO147450C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolonderivater
SE7612202L (sv) Nya aminobensoesyraamider och forfarande for framstellning av dessa.
SE7513571L (sv) Forfarande for framstellning av nya substituerade pyridiner
NO141013C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive bifenylyl-derivater
NO151040C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-halogenpyrimid-2-oner
NO142033C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive isopropylamino-3-fenoksypropanoler
NO142838C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater
SE7510988L (sv) Nya farmaceutiskt aktiva foreningar
NO141894C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive pyridobenzodiazepinoner
NO146199C (no) Fremgangsmaate for fremstilling av alfa-6-deoksy-5-hydroksytetracyklin-hydroklorid
SE405598B (sv) Forfarande for framstellning av nya terapeutiskt verksamma derivat av 4-(3-amino-2-hydroxi-propoxi)-indol
NO810816L (no) Utgangsmateriale for fremstilling av terapeutisk aktive aminosyrederivater
NO144108C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-benzylpiperid-4-yl)-benzamider
NO140012C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive derivater av naftyridin
SE411754B (sv) Forfarande for framstellning av terapeutiskt aktiva nya derivat av n-(2-pyrrolidinylalkyl)-bensamid
NO137894C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive amidoksimer
SE428688B (sv) Forfarande for framstellning av nya antidiabetiskt aktiva isooxazolderivat
NO143499C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indanderivater
NO145238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydrokarbostyril-derivater
NO143317C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive tiazindioksyder
SE402106B (sv) Forfarande for framstellning av nya n-(Ÿ-amino)-alkylanilinderivat
SE414029B (sv) Forfarande for framstellning av terapeutiskt aktiva fentiazinderivat

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7502342-4

Effective date: 19931008

Format of ref document f/p: F